Home / In Silico Workbench / Compound Screening Dashboard

Compound Screening Dashboard

Compound Screening Dashboard

Based on rapidly emerging information on COVID-19, how do we prioritize candidate therapeutics for antiviral use in a pandemic? In the Clinical Pharmacology Triage section of this Compound Screening Dashboard, you can select compounds of interest and then access a heat map that shows which ones rate high and low on proof of hope for COVID-19, based on key metrics such as Cmax/EC50 and Cminss/EC50.

The in silico workbench is intended for use by researchers to assist with clinical trial design and for exploratory and educational purposes. It is NOT intended for use in the diagnosis, cure, mitigation or treatment of any disease. Data provided are not intended to suggest that any product and/or dosing regimen are safe and effective for any use and are for informational purposes only. Please see Terms and Conditions for additional information.